Pfizer (PFIZER.NS) Akcija Kursas
Pfizer Kursas
Pajamos augo 7,0 % per metus per pastaruosius 19 metus iki 25,20 mlrd. INR. Pelnas akcijai augo 10,6 % per metus per pastaruosius 19 metus. Pfizer grynoji marža dabar yra 28,7 %, išaugo nuo 23,5 % prieš kelerius metus. Pfizer šiuo metu siūlo apie 3,57 % dividendo pajamingumą. Išmokų koeficientas yra apie 37 % pelno. Dividendas augo 9,7 % per metus per pastaruosius 19 metus. Analitikų tikslinės kainos mediana yra 6 222,00 INR, t. y. virš dabartinę kainą 71,0 %. Iš 8 analitikų 5 rekomenduoja pirkti — bendras konsensusas yra Pirkti.
Pfizer akcijos kaina
Gaukite šiuos duomenis per Eulerpool API
100 000 užklausų/mėn. nemokamai · be kortelės
Pfizer akcija ir akcijų analizė
Dažnai užduodami klausimai apie Pfizer akciją
The business model of Pfizer Ltd revolves around pharmaceutical research, development, manufacturing, and sales. As a leading global biopharmaceutical company, Pfizer focuses on discovering breakthrough medicines and vaccines for various health conditions. With a diverse portfolio, Pfizer aims to improve patient lives and promote better health outcomes by investing in innovative research and development. Through strategic partnerships and collaborations, Pfizer strives to advance healthcare solutions while maintaining a strong commitment to delivering quality products. By upholding high standards of scientific integrity and ethical business practices, Pfizer continues to contribute to the well-being of individuals worldwide.
Pfizer Ltd is primarily active in the pharmaceutical industry. Its core business focuses on the research, development, manufacture, and sale of a wide range of pharmaceutical products. Pfizer Ltd is a renowned global pharmaceutical company, known for its breakthrough medicines and innovative therapies across various therapeutic areas. With a strong presence in the healthcare sector, Pfizer Ltd strives to enhance and improve the well-being of individuals worldwide.
The main competitors of Pfizer Ltd in the market include pharmaceutical companies such as Johnson & Johnson, Merck & Co., GlaxoSmithKline, and Novartis.
Pfizer Ltd. is a renowned pharmaceutical company with a rich history and background. Founded in 1849, Pfizer has evolved into a leading global player in the healthcare industry. With headquarters in the United States, the company has expanded its reach worldwide, including operations in India through Pfizer Ltd. Pfizer Ltd. is committed to discovering, developing, and manufacturing innovative medicines, vaccines, and consumer healthcare products. The company's relentless pursuit of medical advancements and dedication to improving people's lives has earned Pfizer Ltd. a strong reputation and recognition as a trusted name in the pharmaceutical sector.
Pfizer Ltd, a renowned pharmaceutical company, has achieved several significant milestones over the years. Notably, Pfizer is credited with the development of life-saving drugs like Viagra, Lipitor, and Zoloft, which have had a tremendous impact on global healthcare. Pfizer's contributions in the fields of immunology, oncology, and cardiology have not gone unnoticed, establishing the company as a leader in medical advancements. Pfizer's commitment to research and innovation has resulted in groundbreaking treatments, ensuring better clinical outcomes for patients worldwide. This dedication to excellence and their bold pursuit of scientific breakthroughs have made Pfizer Ltd a trusted and influential player in the pharmaceutical industry.
Pfizer Ltd, a leading pharmaceutical company, has a prominent presence in various countries and regions globally. The company operates in several key markets, including the United States, Europe, Asia-Pacific, Latin America, and Africa. With its headquarters in New York, Pfizer Ltd has established a strong foothold in the United States, utilizing its extensive network for research, development, and distribution of innovative healthcare solutions. Additionally, Pfizer Ltd's operations span across Europe, where it operates in numerous countries, catering to diverse healthcare needs. Further, the company's presence extends to the Asia-Pacific region, Latin America, and Africa, emphasizing its commitment to addressing global health challenges effectively.
Pfizer Ltd represents a set of core values and a strong corporate philosophy. As a renowned pharmaceutical company, Pfizer Ltd is committed to innovation and scientific advancement in the healthcare industry. The company believes in providing high-quality and safe medications to improve patient outcomes. Pfizer Ltd also emphasizes integrity, ethical practices, and transparency in all aspects of its operations. With a dedication to research and development, Pfizer Ltd aims to discover and deliver life-saving and life-enhancing therapies for people worldwide. This commitment, along with a customer-centric approach, makes Pfizer Ltd a trusted name in the pharmaceutical sector.
Analitikai šiuo metu nustato vidutinę Pfizer akcijos tikslinę kainą 6 389,08 INR (mediana: 6 222,00 INR), t. y. +73,2 % palyginti su paskutine kaina. Konsensusas pagrįstas 8 analitikų reitingais.
9 analitikai šiuo metu vertina Pfizer akciją: 6 rekomenduoja pirkti, 3 laikyti ir 0 parduoti.
Pagal dabartinį kursą Pfizer akcija kainuoja 34,33 EUR (3 638,70 INR).
Pfizer akcija (PFIZER.NS) kotiruojama 2 biržose, įskaitant: NSE (Indien) (PFIZER.NS).
Pfizer Ltd is a pharmaceutical company that focuses on the research, development, and marketing of products for the prevention and treatment of diseases. It has a global customer base and operates in various medical fields such as oncology, immunology, neurology, and infectious diseases. The company offers a wide range of medications, from well-established drugs to new therapies and biotechnological products. Its business model is centered on growth and profitability, with investments in research and development to remain competitive. Pfizer Ltd is organized into different divisions, including oncology, infectious diseases, immunology, and neurology, and also engages in the development of biotechnology products. Its products are marketed globally through pharmaceutical distribution channels. Overall, Pfizer Ltd strives to improve the health of patients worldwide through the development and marketing of innovative therapies.
pelnas Pfizer yra 25,20 mlrd. INR. Šis skaičius grindžiamas dabartiniais finansiniais duomenimis ir atspindi įmonės verslo rezultatus.
grynasis pelnas Pfizer yra 7,22 mlrd. INR. Grynasis pelnas atspindi įmonės pelningumą po visų išlaidų atimties.
Kainų ir nuomos santykis (KGV) Pfizer šiuo metu yra 23,04. KGV lygina dabartinę akcijos kainą su pelnu už akciją ir padeda investuotojams įvertinti Pfizer akcijos vertę.
Kainų ir pardavimų santykis (KUV) Pfizer šiuo metu yra 6,61. KUV lygina rinkos kapitalizaciją su metinėmis pajamomis ir yra Pfizer akcijos įvertinimo metrika.
Eulerpool kokybės balas Pfizer yra 5/10.
Pfizer ISIN yra INE182A01018. ISIN (International Securities Identification Number) yra pasaulinė unikali vertybinių popierių identifikacijos sistema.
Pfizer prekybos žymė yra PFIZER.NS. Ši biržos žymė naudojama Pfizer akcijoms prekiauti biržoje.
Pfizer akcija
Pfizer Pagrindiniai konkurentai
Pfizer Biržos simbolis
Pfizer FIGI
Visos Pfizer pagrindinės charakteristikos ir giluminė analizė
Mūsų akcijų analizė Pfizer akcijai apima svarbius finansinius rodiklius, tokius kaip apyvarta, pelnas, P/E santykis, P/S santykis, EBIT, taip pat informaciją apie dividendes. Be to, mes nagrinėjame aspektus, tokius kaip akcijos, rinkos kapitalizacija, skolos, nuosavas kapitalas ir įsipareigojimai Pfizer. Jei ieškote išsamesnės informacijos šiais klausimais, mūsų poskyriuose galite rasti išsamias analizes: